Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 4, 2019 9:37 AM 7 min read

These Are The Leveraged ETFs At Play When Trade War Worries Strike

by Direxion
Follow

The U.S.-China trade war is more than 18 months old. And in that time the conflict has taken a toll on stocks across the world and put company executives and market watchers alike on edge.

Traders just weathered another bout of tariff-related volatility in the wake of President Trump’s latest round of tariffs. The announcement from the most recent escalation managed not only to sack the S&P 500 by more than -6.5%, but caused a mad dash to bonds and treasury notes that resulted in another inversion of the 2-year/10-year Treasury yields curve, further exacerbating the equity sell-off.

Nevertheless, the equity market has bounced back; as it did following the March 2018 sell-off as the first round of tariffs were introduced; as it did following the September 2018 sell-off in response to a second round of tariffs; as it did following the May 2019 sell-off as the Trump administration introduced legislation to ban Chinese telecom firm Huawei from doing business in the U.S.; as it has done on numerous rumors of failed negotiations, bad faith accusations and an array of other dead-end truces and false accords.

The point is, the market has been here before, and many of the same industries keep getting knocked down only to get back up again for another go. In the case of such consistent market patterns, traders often turn to leveraged ETFs to capture some of the directionality of these moves.

While there’s no telling if and when a lasting bear market will finally strike the U.S. exchanges as a result of the interminable trade war, the leveraged sector ETFs below are among the most consistently affected by the many bumps along the road to peace.

Semiconductors

Long before the trade war kicked off in earnest, many on Wall Street predicted semiconductors would be hit particularly hard in any trade dispute with China. In 2018, as the trade war was ramping up, China spent more on chip imports than it did on oil and Chinese tech firm Huawei alone purchased more than $11 billion on semiconductor components from American manufacturers.

The fallout from the tariffs is plain to see in many of the largest semi companies. Revenue for GPU industry leader Nvidia Inc. (NASDAQ:NVDA) is down 24% in the first quarter of 2019 compared to this time last year, while sales for competitor Advanced Micro Devices, Inc. (NASDAQ:AMD) is down 17%.

In the 18 months since the China Tariffs were first announced, Direxion Daily Semiconductor Bear 3X Shares (NYSE:SOXS) has spiked by as much as 20% in a single day, and has made double-digit percentage moves as recently as mid-August.

Conversely, the Direxion Daily Semiconductor Bull 3X Shares (NYSE:SOXL) has rebounded three times in that same span to bump up against an all-time high just above the $200 level.

Technology

Unsurprisingly, technology names as a whole have been susceptible to the trade spat since the troubles faced by chip makers and component manufacturers like Intel Corporation (NASDAQ:INTC) and QUALCOMM Inc. (NASDAQ:QCOM) impact company all along the supply chain.

Biotech

Although the global investment pattern has continued unabated, U.S. companies are seeing less capital due to the trade war. Investment from China to the U.S. has been cut nearly in half in the first six months of 2019 compared to the same span last year.

An investor should carefully consider a Fund’s investment objective, risks, charges, and expenses before investing. A Fund’s prospectus and summary prospectus contain this and other information about the Direxion Shares. To obtain a Fund’s prospectus and summary prospectus call 866-476-7523 or visit our website at direxion.com. A Fund’s prospectus and summary prospectus should be read carefully before investing.

Distributor: Foreside Fund Services, LLC.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Sector ETFsTrading IdeasETFsdirexiontariffsUS-China Trade War
AAPL Logo
AAPLApple Inc
$271.60-0.20%
Overview
AMD Logo
AMDAdvanced Micro Devices Inc
$214.680.39%
INTC Logo
INTCIntel Corp
$46.340.48%
LABD Logo
LABDDirexion Daily S&P Biotech Bear 3X Shares
$16.86-0.65%
LABU Logo
LABUDirexion Daily S&P Biotech Bull 3X Shares
Not Available-%
MSFT Logo
MSFTMicrosoft Corp
$389.840.22%
NVDA Logo
NVDANVIDIA Corp
$193.830.51%
QCOM Logo
QCOMQualcomm Inc
$145.250.32%
SOXL Logo
SOXLDirexion Daily Semiconductor Bull 3X Shares
$69.681.68%
SOXS Logo
SOXSDirexion Daily Semiconductor Bear 3X Shares
$1.63-1.81%
TECL Logo
TECLDirexion Technology Bull 3X Shares
Not Available-%
TECS Logo
TECSDirexion Technology Bear 3X Shares
Not Available-%
TWST Logo
TWSTTwist Bioscience Corp
$47.72-1.69%


Charts via Yahoo Finance; Data as of 9/4/19. Past performance is not indicative of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.  Current performance may be lower or higher than the performance data quoted. For standardized performance, click here.

But tech traders have also punished mega-cap consumer tech names like Apple Inc. (NASDAQ:AAPL) and, to a lesser extent, Microsoft Corporation (NASDAQ:MSFT) for the damage the trade tariffs are doing to those companies’ sales in the quickly expanding Chinese consumer market. Apples’ China revenue fell by more than $5 billion year-over-year in its first-quarter report, and Chinese sales of the company’s iPhone fell 14% in the most recent quarter, losing most of its market share to phones produced by Huawei.

Although the Direxion Daily Technology Bear 3X Shares (NYSE:TECS) has shown some strong moves since the start of the trade war, moving as much a 15% intraday, it’s really the rush back into tech that has continuously propelled the Direxion Daily Technology Bull 3X Shares (NYSE:TECL) from multi-week lows to new all-time highs.


Charts via Yahoo Finance; Data as of 9/4/19. Past performance is not indicative of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.  Current performance may be lower or higher than the performance data quoted. For standardized performance, click here.

Finally, and perhaps most unexpectedly, the biotech sector has been surprisingly vulnerable to breakdowns in negotiations. Although, maybe it’s not so surprising, as China’s ambitions as a global economic leader also extend to pharmaceutical developments. Over the course of 2018, that ambition manifested itself as $137 billion in capital invested in biotech and research firms across the globe to develop new, non-generic prescription medicines.

In fact, pharmaceutical concern Twist Bioscience Corporation (NASDAQ:TWST) recently came under congressional scrutiny for its recent partnership with a Chinese investor that includes setting up operations in the country after previously receiving funding from the U.S. Department of Defense. 

While it’s difficult to quantify exactly the toll this has taken on domestic biotech stocks, especially given other headwinds in the industry like slowing M&A, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE:LABU) has nonetheless fallen significantly from its all-time high set back in June 2018. Most of the major short-term moves related to the trade war have instead come from the Direxion Daily S&P Biotech Bear 3X Shares (NYSE:LABD), which has seen several intraday moves above 10% in the past month alone and has previously jumped by as much as 15% in a single session over 2018.


Charts via Yahoo Finance; Data as of 9/4/19. Past performance is not indicative of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.  Current performance may be lower or higher than the performance data quoted. For standardized performance, click here.

Shares of the Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from a Fund. Market Price returns are based upon the midpoint of the bid/ask spread at 4:00 pm EST (when NAV is normally calculated) and do not represent the returns you would receive if you traded shares at other times. Brokerage commissions will reduce returns. Fund returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV. Some performance results reflect expense reimbursements or recoupments and fee waivers in effect during certain periods shown. Absent these reimbursements or recoupments and fee waivers, results would have been less favorable.

Direxion Shares Risks - An investment in the ETFs involves risk, including the possible loss of principal. The ETFs are non-diversified and include risks associated with concentration that results from an ETF’s investments in a particular industry or sector which can increase volatility. The use of derivatives such as futures contracts and swaps are subject to market risks that may cause their price to fluctuate over time. The ETFs do not attempt to, and should not be expected to, provide returns which are a multiple of the return of their respective index for periods other than a single day. For other risks including leverage, correlation, daily compounding, market volatility and risks specific to an industry or sector, please read the prospectus.

AAPL Logo
AAPLApple Inc
$271.60-0.20%
Overview
AMD Logo
AMDAdvanced Micro Devices Inc
$214.680.39%
INTC Logo
INTCIntel Corp
$46.340.48%
LABD Logo
LABDDirexion Daily S&P Biotech Bear 3X Shares
$16.86-0.65%
LABU Logo
LABUDirexion Daily S&P Biotech Bull 3X Shares
Not Available-%
MSFT Logo
MSFTMicrosoft Corp
$389.840.22%
NVDA Logo
NVDANVIDIA Corp
$193.830.51%
QCOM Logo
QCOMQualcomm Inc
$145.250.32%
SOXL Logo
SOXLDirexion Daily Semiconductor Bull 3X Shares
$69.681.68%
SOXS Logo
SOXSDirexion Daily Semiconductor Bear 3X Shares
$1.63-1.81%
TECL Logo
TECLDirexion Technology Bull 3X Shares
Not Available-%
TECS Logo
TECSDirexion Technology Bear 3X Shares
Not Available-%
TWST Logo
TWSTTwist Bioscience Corp
$47.72-1.69%
Comments
Loading...